|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 9/00 | |
| A61K 9/10 | |||
| A61K 9/16 |
| (11) | Number of the document | 2849723 |
| (13) | Kind of document | T |
| (96) | European patent application number | 13724493.5 |
| Date of filing the European patent application | 2013-05-17 | |
| (97) | Date of publication of the European application | 2015-03-25 |
| (45) | Date of publication and mention of the grant of the patent | 2018-05-02 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2013/041532 |
| Date | 2013-05-17 |
| (87) | Number | WO 2013/173687 |
| Date | 2013-11-21 |
| (30) | Number | Date | Country code |
| 201261649146 P | 2012-05-18 | US |
| (72) |
ARMSTRONG, Nicholas J., US
BOWEN, Mayumi N., US
MAA, Yuh-Fun, US
|
| (73) |
Genentech, Inc.,
1 DNA Way, South San Francisco, CA 94080,
US
|
| (54) | HIGH-CONCENTRATION MONOCLONAL ANTIBODY FORMULATIONS |
| HIGH-CONCENTRATION MONOCLONAL ANTIBODY FORMULATIONS |